Salute e Benessere
$1.3 Billion Quantum Computing in Healthcare Market Poised for 37.9% CAGR Growth | MarketsandMarkets™
The global , valued at US$191.3 million in 2024, stood at US$265.9 million in 2025 and is projected to advance at a resilient CAGR of 37.9% from 2025 to 2030, culminating in a forecasted valuation of US$1324.2 million by the end of the period. This acceleration isn't speculative—it's driven by urgent healthcare demands, exponential data growth, and a race toward AI-powered personalization in medicine. For C-level executives, this is no longer a question of 'if', but '
In fields like , , and , conventional computing hits a wall. Quantum systems break through—modeling molecular complexity, running probabilistic simulations, and enabling precise diagnostics in seconds rather than weeks. When paired with AI, quantum computing becomes a force multiplier, at scale.
Healthcare inefficiencies—from slow drug discovery pipelines to poor diagnostic accuracy—cost billions. Quantum computing , enhances genomics analysis, and brings real-time modeling to clinical decisions. It's already reshaping how pharmaceutical and biotech firms design molecules, conduct trials, and bring therapies to market faster.
Rapid digitalization and rising healthcare needs are positioning as next-gen quantum hubs. These regions are benefiting from , , and , enabling quantum healthcare innovation without Western regulatory drag.
Market leaders include , , , , , , and . IBM's Quantum System One is operational at Cleveland Clinic. IonQ, NVIDIA, and AstraZeneca are building real-world workflows in quantum-enhanced drug discovery. Startups like , , and are pushing quantum boundaries in AI diagnostics and clinical modeling. Together, the top players command .
It's not just about hardware—it's about . Quantum still battles high error rates, steep costs, and talent shortages. Organizations that succeed will invest in , , and . The true barrier is , not technical readiness.
Precision is no longer a luxury—it's the competitive edge. With billions at stake in R&D savings, patient outcomes, and faster go-to-market strategies, . It brings under one scalable platform.
For more information,
Get access to the latest updates on and
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, , and . With a , we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our , which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
Logo: https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/1-3-billion-quantum-computing-in-healthcare-market-poised-for-37-9-cagr-growth--marketsandmarkets-302501033.html